Single dose typhoid conjugate vaccine provides lasting efficacy in children

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old,

Guardian Editor

Latest news today on lasting efficacy

Single dose typhoid conjugate vaccine provides lasting efficacy in children

Subsidy politics: Fiscal gain, household pain shape 2027 election

Parties trade blame as Kaduna incident, intimidation fuel election fears

2027: Kwankwaso urges Atiku to quit race as Obi rules out stepping down

ADC: A party divided over gubernatorial candidacy in Adamawa

Single dose typhoid conjugate vaccine provides lasting efficacy in children

The News You Need, Delivered To You.